Article
Cognitive performance in neurokinin 3 receptor knockout mice.
Psychopharmacology - 1 Jun 2008
Nordquist R E, Delenclos M, Ballard T M, Savignac H, Pauly-Evers M, Ozmen L, Spooren W
Abstract excerpt
RATIONALE: The neurokinin 3 (NK(3)) receptor is a novel target under investigation for improvement of the symptoms of schizophrenia due to its ability to modulate dopaminergic signaling. However, research on effects of NK(3) antagonism with animal models has been hindered because of species differences in the receptor between humans, rats, and mice. OBJECTIVES: The aim of the present study is to further knowledge...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
